Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of brucellosis
3.2.1.2 Increasing livestock production
3.2.1.3 Rising awareness about zoonotic diseases
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory requirements for animal vaccines
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 RB51 vaccines
5.3 S19 vaccines
5.4 B19 vaccines
5.5 Other types
Chapter 6 Market Estimates and Forecast, By Vaccine, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 DNA vaccines
6.3 Subunit vaccines
6.4 Vector vaccines
6.5 Recombinant vaccines
Chapter 7 Market Estimates and Forecast, By Animal Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Cattle
7.3 Sheep
7.4 Goat
7.5 Other animal type
Chapter 8 Market Estimates and Forecast, By End-user, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Veterinary clinics & hospitals
8.3 Animal care centers
8.4 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Ceva
10.2 Colorado Serum Company
10.3 Creative Biolabs
10.4 CZ Vaccines
10.5 Fivet Animal Health
10.6 Hester Biosciences Limited
10.7 Indian Immunologicals Ltd.
10.8 Jordan Bio-industries Center
10.9 Laboratories Tornel
10.10 Merck & Co., Inc.
10.11 VETAL Animal Health Products Inc.
10.12 Veterinary Technologies Corporation
